(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q9)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -15.94%45.8M | 16.67%85.62M | 20.88%54.49M | 5.27%25.64M | -7.00%73.38M | 2.23%65.66M | 1.64%45.07M | 14.23%24.36M | 41.79%78.9M | 70.92%64.23M |
Operating income | -15.94%45.8M | 16.67%85.62M | 20.88%54.49M | 5.27%25.64M | -7.00%73.38M | 2.23%65.66M | 1.64%45.07M | 14.23%24.36M | 41.79%78.9M | 70.92%64.23M |
Cost of sales | 10.25%-19.28M | 5.82%-37.08M | -10.12%-21.49M | 2.64%-10.37M | -4.09%-39.38M | -13.19%-32.79M | -8.84%-19.51M | -15.84%-10.65M | -38.50%-37.83M | -61.34%-28.97M |
Operating expenses | 10.25%-19.28M | 5.82%-37.08M | -10.12%-21.49M | 2.64%-10.37M | -4.09%-39.38M | -13.19%-32.79M | -8.84%-19.51M | -15.84%-10.65M | -38.50%-37.83M | -61.34%-28.97M |
Gross profit | -19.65%26.52M | 42.71%48.53M | 29.10%33M | 11.42%15.28M | -17.21%34.01M | -6.77%32.87M | -3.24%25.56M | 13.02%13.71M | 44.96%41.08M | 79.69%35.26M |
Administrative expenses | -8.96%-14.49M | -12.89%-30.71M | -4.76%-13.3M | 2.81%-6.01M | 2.87%-27.21M | -5.09%-18.78M | -5.71%-12.69M | -6.03%-6.19M | -17.31%-28.01M | -6.97%-17.87M |
Impairment and provision | ---- | -288.21%-1.71M | ---- | ---- | -39.56%-441K | -91.75%24K | -91.72%24K | ---- | 57.35%-316K | 88.96%291K |
-Other impairment is provision | ---- | -288.21%-1.71M | ---- | ---- | -39.56%-441K | -91.75%24K | -91.72%24K | ---- | 57.35%-316K | 88.96%291K |
Special items of operating profit | -21.34%1.14M | 77.13%1.98M | 109.55%1.45M | 233.20%321K | 21.20%1.12M | 52.09%1.05M | -6.37%691K | -1,821.43%-241K | -67.56%920K | -74.95%693K |
Operating profit | -37.76%13.17M | 141.93%18.08M | 55.71%21.15M | 31.59%9.59M | -45.32%7.47M | -17.43%15.17M | -12.01%13.58M | 11.36%7.28M | 108.59%13.67M | 214.73%18.37M |
Financing cost | -22.35%-104K | 40.71%-134K | 12.37%-85K | -11.90%-47K | -73.85%-226K | -54.55%-170K | -19.75%-97K | 4.55%-42K | 26.14%-130K | 21.43%-110K |
Earning before tax | -38.00%13.06M | 147.63%17.95M | 56.19%21.07M | 31.70%9.54M | -46.47%7.25M | -17.87%15M | -12.18%13.49M | 11.47%7.24M | 112.31%13.54M | 220.53%18.26M |
Tax | 44.11%-2.14M | -122.19%-2.49M | -86.57%-3.83M | 42.41%-713K | 48.25%-1.12M | 15.74%-2.61M | 0.48%-2.06M | -19.85%-1.24M | -128.69%-2.17M | -231.91%-3.1M |
After-tax profit from continuing operations | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M | 109.45%11.37M | 218.30%15.16M |
Earning after tax | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M | 109.45%11.37M | 218.30%15.16M |
Profit attributable to shareholders | -36.64%10.92M | 152.29%15.46M | 50.73%17.23M | 46.99%8.83M | -46.13%6.13M | -18.30%12.39M | -13.99%11.43M | 9.88%6M | 109.45%11.37M | 218.30%15.16M |
Basic earnings per share | -36.63%0.0109 | 154.10%0.0155 | 50.88%0.0172 | 46.67%0.0088 | -46.49%0.0061 | -18.42%0.0124 | -14.29%0.0114 | 9.09%0.006 | 111.11%0.0114 | 216.67%0.0152 |
Diluted earnings per share | -36.63%0.0109 | 154.10%0.0155 | 50.88%0.0172 | 46.67%0.0088 | -46.49%0.0061 | -18.42%0.0124 | -14.29%0.0114 | 9.09%0.006 | 111.11%0.0114 | 216.67%0.0152 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | -- | Furimazer Certified Public Accountants Limited | -- | -- | -- | Furimazer Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data